Ligand Pharmaceuticals | LGND - 流动资产



金融业
股票价格
USD
资产
USD 2.19B
现金及等价物
USD 1.01B
销售成本
USD 11.31M
流动资产
USD 1.46B
流动负债
USD 46.74M
债务
USD 451.98M
EBIT
USD 56.62M
EBITDA
USD -14.3M
员工
68
EPS每股收益
USD 2.37
股本和储备
USD 967.52M
销售毛利
USD 100.41M
债务利息支出
USD 1.79M
利息收入
USD 6.66M
贷款资金
USD 446.9M
市值
USD 5.23B
净收入
USD 48.51M
营业费用
USD 55.1M
营业利润
USD 56.62M
普通股股本
USD 19.66M
PE价格收益
84.31
税前利润
USD -24.26M
销售收入
USD 83.7M
销售和管理费用
USD 29.12M
股票
USD 10.26M
贸易债权人
USD 9.41M
应收帐款人
USD 54.8M


流动资产 更改 日
Agenus USD 78.81M 16.47M 2026-06
Amgen USD 34.96B 3.49B 2026-06
Anika Therapeutics USD 99.19M 5.63M 2026-06
Arrowhead Research USD 1.67B 168.34M 2026-06
Baxter International USD 6.99B 142M 2026-06
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Enanta Pharmaceuticals USD 198.68M 5.65M 2025-12
Enviri Corporation USD 722.11M 1.43M 2026-03
Gilead Sciences USD 12.53B 6.11B 2026-06
GlaxoSmithKline GBP 17.56B 202M 2026-06
Glaxosmithkline GBP 17.76B 5.83B 2026-03
Heron Therapeutics USD 229.84M 861K 2026-06
Insmed USD 1.63B 20.75M 2026-06
Intrexon USD 23.72M 45.04M 2024-06
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
Karyopharm Therapeutics USD 126.33M 23.19M 2026-03
Ligand Pharmaceuticals USD 1.46B 591.7M 2026-06
MacroGenics USD 321.69M 139.16M 2026-06
Merck USD 36.68B 1.66B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Veracyte USD 574.78M 52.6M 2026-06